Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
ExCellThera's stem cell expansion approach may benefit AML patients undergoing transplants

ExCellThera's stem cell expansion approach may benefit AML patients undergoing transplants

TGen, Phoenix Children's Hospital developing new methods to store and transport blood samples

TGen, Phoenix Children's Hospital developing new methods to store and transport blood samples

Experts review strategies that may help improve adoptive cell immunotherapy for treating cancer

Experts review strategies that may help improve adoptive cell immunotherapy for treating cancer

Molecules derived from avocados could help combat acute myeloid leukemia

Molecules derived from avocados could help combat acute myeloid leukemia

Combination of tosedostat and LDAC results in overall response rate of 54% in elderly patients with AML

Combination of tosedostat and LDAC results in overall response rate of 54% in elderly patients with AML

NeoGenomics announces launch of new NeoLAB assays to diagnose hematologic diseases

NeoGenomics announces launch of new NeoLAB assays to diagnose hematologic diseases

Protein-signaling process accelerates work of gene mutation linked to common form of adult leukemia

Protein-signaling process accelerates work of gene mutation linked to common form of adult leukemia

Researchers examine specific causes of mortality after blood and marrow transplant

Researchers examine specific causes of mortality after blood and marrow transplant

Researchers identify potential treatment option for childhood leukemia

Researchers identify potential treatment option for childhood leukemia

US cancer physicians explore new approach to help older patients undergoing hematopoietic stem cell transplant

US cancer physicians explore new approach to help older patients undergoing hematopoietic stem cell transplant

Enhancing body's gut defense system can reverse bloodstream infections

Enhancing body's gut defense system can reverse bloodstream infections

Researchers report new way to treat T-cell acute lymphoblastic leukemia

Researchers report new way to treat T-cell acute lymphoblastic leukemia

Janssen begins rolling submission of daratumumab BLA to FDA for treatment of patients with multiple myeloma

Janssen begins rolling submission of daratumumab BLA to FDA for treatment of patients with multiple myeloma

Research shows how social network analysis can help identify cancer biomarkers

Research shows how social network analysis can help identify cancer biomarkers

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

Transwestern named a finalist in 2015 NJBIZ Healthcare Heroes awards program

Transwestern named a finalist in 2015 NJBIZ Healthcare Heroes awards program

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

Phase 2 results from Abbvie’s veliparib study in NSCLC presented at ASCO 2015

Phase 2 results from Abbvie’s veliparib study in NSCLC presented at ASCO 2015

Novartis CTL019 CAR T cell therapy demonstrates potential to treat B-cell lymphomas

Novartis CTL019 CAR T cell therapy demonstrates potential to treat B-cell lymphomas

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.